Clinical Trial Update: Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating S-1 maintenance therapy in unresectable, locally advanced or metastatic gastric/GEJ adenocarcinoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Stomach
• Esophageal Adenocarcinoma
• Esophageal Neoplasms
• Gastric Adenocarcinoma
• Gastric Neoplasm
• Gastroesophageal Junction Adenocarcinoma
• Stomach Neoplasms

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastric Neoplasm | Phase 2 | Status: COMPLETED